New Version of Market-Leading Product Meets Patient Demand for Access to Data, Enabling Improved Engagement and Outcomes BOSTON, MA /...
MCLEAN, VA / ACCESSWIRE / October 15, 2024 / Dr. Amir Bajoghli and the Skin & Laser Dermatology Center are...
The salon's commitment to its clients and craft has helped it continue to rank as a top choice for lash...
TORONTO, ON / ACCESSWIRE / October 15, 2024 / Ripple Therapeutics Corporation, a clinical stage company focused on improving ophthalmic...
MAULDIN, SC / ACCESSWIRE / October 15, 2024 / Xcelerate, Inc.'s (OTCQB:XCRT) CEO, Mike O'Shea, today released this letter and...
KELOWNA, BC / ACCESSWIRE / October 15, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator...
CBD Life Sciences propels its expansion with a major MOU, positioning the company for multi-million-dollar growth in the booming $14.6...
In partnership with statewide health clinics and organizations, Revival Health and former Governor Phil Bryant join forces to tackle Mississippi's...
ZURICH, SWITZERLAND / ACCESSWIRE / October 15, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
Thought Leader in Brain Health Joins Richard Stark and Company Co-Founders to Accelerate Innovation in Precision MedicineMONTREAL, QC / ACCESSWIRE...
Leading veterinary experts to present educational programs featuring Zomedica product applications at the Fetch dvm360 Veterinary Conference ANN ARBOR, MI...
SHELTON, CT / ACCESSWIRE / October 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader...
- GPS Currently Investigated in Phase 3 REGAL Trial in Adult AML Patients – Interim Analysis Anticipated in Q4 2024...
U.S. Food and Drug Administration (FDA) Submission Expected by end of 2024 Clinical Data to be Presented at Medical Conference...
BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of...
Webinar to focus on a nephrologist’s perspective on the use of FUROSCIX for fluid overload in heart failure and potential...
SAN FRANCISCO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development...
SAN JOSE, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a...
DENVER, Oct. 15, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary...
MINNEAPOLIS, MN, Oct. 15, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), provides a shareholder letter from...